Although the expression of TP73 was not significantly associated with any clinical characteristics in this study, likely due to limited sample size, higher TP73 was reported to be significantly associated with lower mean survival in a larger cohort of 193 HCC patients [34] and higher levels of lymph node metastasis, vascular invasion and pathological staging in breast cancer [35]. Here, TP73 is linked to breast carcinoma.